Moreover, the introduction of the NK-cell costimulatory domain (DNAM1 and 2B4) further optimized the GPC3-specific CAR construction, allowing CAR NK-92 cells to exhibit stronger proliferation and anti-apoptotic ability and achieve predominate cytotoxicity against HCC cells in vitro [138]. Here, GPC3 is linked to hepatocellular carcinoma.